Printer Friendly

The bottom line.

The Bottom Line

Data from recent industry financial reports. Dollar amounts
in millions.

Company             Period    Ended    Sales    Chg.    Op. Prof.

Axon Instruments       4Q    31-Dec    $35.7    25.2%     ($0.9)
Biacore                1Q    31-Mar    $13.5    -1.1%       $2.8
Cell Robotics          4Q    31-Dec     $0.5    87.9%        N/A
Cell Robotics         FYE    31-Dec     $1.6    58.8%     ($2.7)
Cell Robotics          1Q    31-Mar     $0.4    79.9%     ($0.4)
Cuno                   1Q    31-Jan    $58.6     0.1%       $6.9
Cuno                   2Q    30-Apr    $63.1     4.9%       $8.3
CyBio                 FYE    31-Dec    $13.0   -34.2%        N/A
Ionics                 1Q    31-Mar    $80.3   -34.7%       $2.0
Molecular Devices      1Q    31-Mar    $20.6    -0.5%       $0.9
MTS Systems            2Q    31-Mar    $92.0    -6.4%     ($3.2)
MWG-Biotech AG        FYE    31-Dec    $47.2     6.9%    ($16.4)
New Brunswick          1Q    31-Mar    $13.3    -9.8%       $1.0
Newport Corp.          1Q    31-Mar    $43.9   -55.7%     ($3.7)
Pall                   3Q    27-Apr   $302.4    -5.8%      $33.9
Sigma-Aldrich          1Q    31-Mar   $316.9     3.7%      $57.6
Visible Genetics       1Q    31-Mar     $4.3    21.2%    ($10.1)
Zygo                   3Q    31-Mar    $21.3   -45.0%     ($5.9)

Company              Chg.    Net Prof.    Chg.

Axon Instruments        NM       $0.8    -75.3%
Biacore               6.4%       $2.1      4.9%
Cell Robotics          N/A        N/A       N/A
Cell Robotics           NM     ($2.7)        NM
Cell Robotics           NM     ($0.4)        NM
Cuno                 13.6%       $4.5     18.1%
Cuno                 20.2%       $5.4     19.7%
CyBio                  N/A        N/A       N/A
Ionics              -64.5%       $1.9    -35.3%
Molecular Devices   -35.5%       $0.7    -56.0%
MTS Systems             NM     ($1.2)        NM
MWG-Biotech AG          NM        N/A       N/A
New Brunswick       238.3%       $0.6    396.5%
Newport Corp.           NM    ($18.7)        NM
Pall                -28.3%      $26.4    -28.3%
Sigma-Aldrich         8.7%      $39.7      8.4%
Visible Genetics        NM     ($9.9)        NM
Zygo                    NM     ($3.7)        NM

NA=not available NM=not meaningful
COPYRIGHT 2002 Strategic Directions International Inc. (SDI)
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Instrument Business Outlook
Geographic Code:1USA
Date:May 31, 2002
Words:325
Previous Article:Market profile: laboratory distillation.
Next Article:50th Annual ASMS meeting is a roaring success.
Topics:


Related Articles
Words to avoid: the most overused words and phrases in the English language. (Editing).
Investment banker notes how better off newsletters are than business magazines.
Update: Agora and Boardroom partnership going very well.
Linking Customer and Employee Satisfaction to the Bottom Line.
Linking Customer and Employee Satisfaction to the Bottom Line.
Congratulations to--.
Managing intangible assets: if the work you're doing is building needed capabilities, competencies and market value, good. If not, stop--and do...
Advanced Learning Institute.
Getting into college and graduating; Organization helps low-income students get degrees.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters